Snyder Mark Howard 4

4 · HALOZYME THERAPEUTICS, INC. · Filed Feb 17, 2026

AI-generated summary of this filing

Updated Feb 17, 2026

Halozyme (HALO) SVP/CLO Mark Snyder Receives Awards; Shares Withheld

What Happened

Mark Howard Snyder, SVP and Chief Legal Officer of Halozyme (HALO), had equity awards vest/settle on 2026-02-16, resulting in the conversion/acquisition of 16,812 shares (4,796 and 12,016). The issuer withheld 2,587 and 6,481 shares to satisfy tax withholding obligations at $79.44 per share (values $205,511 and $514,851 respectively). Total shares withheld = 9,068, total withholding value ≈ $720,362. The filing shows acquisition entries at $0 (conversion/vesting) and withholding dispositions associated with tax payment.

Key Details

Transaction date: 2026-02-16; Filing date: 2026-02-17 (timely, next-day filing).
Share movements: 16,812 shares acquired via vesting/conversion; 9,068 shares withheld for taxes; net shares retained from the settlement = 7,744 (16,812 − 9,068).
Prices/values: withholding price $79.44 per share; withheld shares valued $205,511 and $514,851 (total ≈ $720,362).
Footnotes: F1/F2 = shares withheld to cover tax withholding; F3 = vesting/settlement of restricted stock units (RSUs); F4 = vesting/settlement of performance stock units (PSUs).
Shares owned after transaction: not specified in the filing.

Context

This was a routine vesting/settlement of RSUs/PSUs with shares withheld by the issuer to cover tax obligations (a common cashless withholding method), not an open-market sale. Such withholding does not necessarily signal a change in the insider’s market view.

Form 4

Period: 2026-02-16

SVP, CHIEF LEGAL OFFICER

Transactions

Exercise/Conversion
Common Stock
2026-02-16+4,796→ 38,977 total
Tax Payment
Common Stock
[F1]
2026-02-16$79.44/sh−2,587$205,511→ 36,390 total
Exercise/Conversion
Common Stock
2026-02-16+12,016→ 48,406 total
Tax Payment
Common Stock
[F2]
2026-02-16$79.44/sh−6,481$514,851→ 41,925 total
Exercise/Conversion
Restricted Stock Units
[F3]
2026-02-16−4,796→ 4,796 total
Exercise: $0.00→ Common Stock (4,796 underlying)
Exercise/Conversion
Performance Stock Units
[F4]
2026-02-16−12,016→ 0 total
Exercise: $0.00→ Common Stock (12,016 underlying)

Footnotes (4)

[F1]The reported disposition of 2,587 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
[F2]The reported disposition of 6,481 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
[F3]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
[F4]This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer.

Signature

/s/ James R. Oehler, Attorney-in-Fact|2026-02-17

1 file